Conclusion
The evidence supports a narrower conclusion than the headline risk suggests: the litigation hurdle was cleared, but the available record does not yet support an exposure materially different from the approximately $3.2 billion in plaintiffs’ estimates. The September 30 ruling preserved a path to trial and damages, while dismissing other claims and awarding no money.
The figures cited are approximately $901 million for Gannett, $600 million for Daily Mail, and $1.72 billion for the publisher class through March 31, 2024, with additional damages claimed afterward. They are plaintiffs’ expert estimates, not judicial findings or a settlement demand established in the retrieved primary record. The independent account says the judge also rejected Google’s effort to exclude key expert testimony, but surviving plaintiffs still must prove causation, injury, and damages.
Evidence
The event is partially verified within the retrieved coverage. The independent Editor & Publisher account reports an 88-page September 30 opinion by Judge P. Kevin Castel in the Southern District of New York. It says core claims by the AdX publisher class and Mikula Web Solutions survived, while claims by Gannett and Daily Mail under New York’s General Business Law, The Progressive’s claims, and Inform’s federal antitrust claims were dismissed. The underlying court opinion itself was not retrievable from the available coverage, so the precise holdings and methodology remain dependent on secondary reporting.
The DOJ primary source independently confirms broader ad-tech antitrust exposure for Google, but it concerns a separate government case in the Eastern District of Virginia and remedies rather than the private damages ruling at issue. The DOJ says Google was ordered to provide interoperability, data-sharing, and anti-discrimination measures, with six years of monitoring. That corroborates continuing regulatory scrutiny of Google’s ad-tech model, but it does not establish private damages or validate the $3.2 billion estimate.
For scale, SEC-derived Alphabet revenue was $445.866 billion for the four quarters ended June 30, 2026, and operating income was $147.628 billion for the same period. The approximately $3.2 billion estimate equals about 0.72% of that revenue and 2.17% of that operating income. This is a rough scale comparison, not an expected loss: the damages may be reduced, rejected, settled, or supplemented by later-accruing claims.
GOOGL closed at $338.24 on October 1, 2026, versus $344.08 on September 30, a decline of approximately 1.70%. The Yahoo/Stocktwits article reported a similar decline. This timing is consistent with a possible market reaction, but the retrieved evidence does not isolate the litigation ruling from other contemporaneous information or establish causation.
What would change the assessment
The assessment would change if the court’s opinion or subsequent trial filings showed that the $901 million, $600 million, and $1.72 billion figures were admitted as reliable damages calculations rather than merely disputed plaintiff estimates; if the court certified a damages class on materially broader claims; if later damages periods substantially increased the claimed amount; or if a judgment, settlement, or reserve disclosed a binding liability.
Conversely, exclusion of expert testimony, failure of plaintiffs to prove causation, denial of class certification, dismissal of surviving claims, or a final damages award materially below the estimates would weaken the exposure thesis. The exact court opinion, trial schedule, expert reports, class-certification record, and any later Alphabet reserve or settlement disclosure are not available in the retrieved evidence.
Next step
Treat the story as a meaningful litigation-risk development, not as a quantified $3.2 billion liability. The next evidence to monitor is the official September 30 opinion and docket, followed by the trial schedule, class-certification decisions, expert methodology rulings, and any damages judgment or settlement. Until those records are available, the narrow answer is that the current evidence does not support exposure materially different from the plaintiffs’ approximately $3.2 billion estimate.